Increased mean platelet volume in patients with slow coronary flow

Nihat Sen1, Nurcan Basar, Orhan Maden

  • 1Department of Cardiology, Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey. nihatdrsen@gmail.com

Platelets
|January 28, 2009
PubMed

Insights

Elevated mean platelet volume (MPV) is linked to slow coronary flow (SCF) in heart disease patients. Higher MPV independently predicts reduced coronary blood flow, suggesting its potential as a marker for SCF.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Diagnostics

Background:

  • Mean platelet volume (MPV) reflects platelet activation, a key factor in coronary heart disease (CAD) pathophysiology.
  • Slow coronary flow (SCF) is associated with severe cardiovascular events, including myocardial infarction and sudden cardiac death.

Purpose of the Study:

  • To investigate the association between MPV levels and the SCF phenomenon in patients with CAD.
  • To determine if MPV is an independent predictor of SCF.

Main Methods:

  • MPV was measured in 84 patients with SCF, 88 patients with CAD, and 84 control subjects.
  • Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) was used to assess coronary blood flow.
  • Statistical analyses, including stepwise linear regression, were performed to identify predictors of TFC.

Main Results:

  • MPV levels were significantly higher in both SCF and CAD groups compared to controls.
  • No significant difference in MPV was found between the SCF and CAD groups.
  • Mean TFC was significantly higher in the SCF group than in the CAD and control groups.
  • MPV was positively correlated with mean TFC and identified as the sole independent predictor of mean TFC.

Conclusions:

  • Elevated MPV is significantly associated with impaired coronary blood flow.
  • Higher MPV levels may serve as an independent predictor for the presence of SCF in patients with CAD.
  • Further research is needed to establish MPV's role in managing SCF-complicated CAD.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...